Committed to Interventional Oncology
TheraSphere™ Y-90 Glass Microspheres
Hit Tumors* hard with TheraSphere, a highly potent, FDA approved Y-90 treatment that allows for personalized dosing to directly attack HCC liver tumors.
Embold™ Detachable Coil System
Introducing Embold Fibered, a purpose-built coil designed to maximize procedural flexibility and reliability.
Eluvia™ Drug-Eluting Stent and Ranger™ Drug-Coated Balloon
Boston Scientific is committed to advancing science in the fight against PAD. Our proven results are backed by Level-1 Randomized Controlled Trials.
Talk to a representative
Want to learn more about products and services? One of our sales representatives will be happy to contact you.
Stay up-to-date with emails on the latest advances, news and innovations in interventional radiology.
*Refers to HCC or associated tumors
TheraSphere is a registered trademark of Theragenics Corporation used under license by Biocompatibles UK Ltd., a wholly owned subsidiary of Boston Scientific Corporation.